You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

angiogenesis inhibition

Showing 1 - 25 of 3,943
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rectal Cancer Trial in Manchester (AZD6244, Cediranib (AZD2171))

Terminated
  • Rectal Cancer
  • Manchester, United Kingdom
    The Christie NHS Foundation Trust
Feb 11, 2021

MDS Trial in Beijing (Lenalidomide, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Metastatic Colorectal Carcinoma Trial (Pentoxifylline, FOLFOX, XELOX)

Not yet recruiting
  • Metastatic Colorectal Carcinoma
  • (no location specified)
Nov 1, 2023

Small Cell Lung Cancer Trial in Suzhou (Chiauranib)

Recruiting
  • Small Cell Lung Cancer
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Suzhou University
Jul 19, 2022

Small Cell Lung Cancer Trial in Beijing (Chiauranib, Placebo)

Recruiting
  • Small Cell Lung Cancer
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
May 4, 2022

Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

Suspended
  • Solid Tumor
  • ARID1A Gene Mutation
  • Greenville, South Carolina
    Prisma Health Cancer Institute
Jan 10, 2023

Small Cell Lung Cancer Trial in Beijing (Chiauranib)

Recruiting
  • Small Cell Lung Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 8, 2022

Purinergic Signaling and the Postmenopausal Heart

Recruiting
  • Diastolic Heart Failure
  • Heart Failure With Preserved Ejection Fraction
  • Gender
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Aug 28, 2023

Oral Cancer Trial in Varanasi (Aspirin 150 mg, Standard of care)

Recruiting
  • Oral Cancer
  • Aspirin 150 mg
  • Standard of care
  • Varanasi, UP, India
    Banaras Hindu University
May 23, 2023

Lymphangioleiomyomatosis Trial in Milan (Nintedanib)

Completed
  • Lymphangioleiomyomatosis
  • Milan, Italy
    Pneumology unit
Sep 26, 2022

Hematuria, Bladder Cancer Trial in Syracuse (Valproic Acid)

Completed
  • Hematuria
  • Bladder Cancer
  • Valproic Acid
  • Syracuse, New York
    SUNY Upstate Medical University
Oct 19, 2021

Type 1 Diabetic Nephropathy Trial in Cairo (oral sitagliptin supplementation)

Completed
  • Type 1 Diabetic Nephropathy
  • oral sitagliptin supplementation
  • Cairo, Egypt
    Nancy Elbarbary
Nov 2, 2023

Soft Tissue Sarcoma Trial in Charleston (Hypofractionated Radiation Therapy)

Not yet recruiting
  • Soft Tissue Sarcoma
  • Hypofractionated Radiation Therapy
  • Charleston, South Carolina
    Medical University of South Carolina
Mar 8, 2023

Metastatic Colorectal Cancer Trial in Tanta (Silymarin)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Tanta, Egypt
    faculty of Pharmacy , Tanta University
Dec 8, 2022

Non Small Cell Lung Cancer Trial in Innsbruck (neoadjuvant therapy with Pembrolizumab/Lenvatinib, Surgery, Adjuvant Treatment

Recruiting
  • Non Small Cell Lung Cancer
  • neoadjuvant therapy with Pembrolizumab/Lenvatinib
  • +2 more
  • Innsbruck, Tirol, Austria
    Medical University Innsbruck
Aug 23, 2022

Exudative Macular Degeneration, Wet Age-related Macular Degeneration Trial in Iowa City (Doxycycline Hyclate, Placebo)

Recruiting
  • Exudative Macular Degeneration
  • Wet Age-related Macular Degeneration
  • Doxycycline Hyclate
  • Placebo
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics Department of Ophthalmolo
Apr 5, 2022

NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Nintedanib, gefitinib, erlotinib, afatinib
  • (no location specified)
Oct 2, 2023

Hepatocellular Carcinoma Trial in Shanghai (Chiauranib)

Completed
  • Hepatocellular Carcinoma
  • Shanghai, Shanghai, China
    Zhongshan Hospital of Fudan University
Jun 15, 2021

Klotho _ LRP-6 _ Gastric Adenocarcinoma

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Prognostic study
  • (no location specified)
Jan 29, 2023

Well Differentiated Pancreatic Endocrine Tumor Trial in Milano (Everolimus plus Octreotide LAR plus Metformin)

Active, not recruiting
  • Well Differentiated Pancreatic Endocrine Tumor
  • Everolimus plus Octreotide LAR plus Metformin
  • Milano, Italy
    Fondazione IRCCS Istituto Tumori Milano
Sep 3, 2021

Angiogenesis, Endometriosis Trial in Patra, Yonago (Leuprolide Acetate)

Completed
  • Angiogenesis
  • Endometriosis
  • Leuprolide Acetate
  • Patra, Peloponnese, Greece
  • +1 more
Oct 27, 2023

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Tucson (Tadalafil 20 MG)

Not yet recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Tadalafil 20 MG
  • Tucson, Arizona
    Arizona Cancer Center at UMC North/University Medical Center
Feb 1, 2023

Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial run by the NCI (durvalumab,

Recruiting
  • Hepatocellular Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Renal Cell Carcinoma Trial in Omaha, Cleveland, Philadelphia (Axitinib)

Terminated
Has Results
  • Renal Cell Carcinoma
  • Omaha, Nebraska
  • +2 more
Jul 26, 2021

Sarcoma Trial in Shanghai (MASCT-I,PD1 Antibody,Apatinib)

Active, not recruiting
  • Sarcoma
  • MASCT-I,PD1 Antibody,Apatinib
  • Shanghai, Shanghai, China
    Shanghai Sixth People's Hospital
Nov 22, 2022